
USFDA APPLICATION NUMBER - 18644 / DOSAGE - TABLET;ORAL - 75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| BUPROPION HYDROCHLORIDE(UNII: ZG7E5POY8O) (BUPROPION - UNII:01ZG3TPX31) | BUPROPION HYDROCHLORIDE | 100mg |
Inactive Ingredients
| Ingredient Name | GlaxoSmithKline LLC | REMEDYREPACK INC. |
|---|---|---|
| CELLULOSE, MICROCRYSTALLINE(OP1R32D61U) | ||
| D&C YELLOW NO. 10(35SW5USQ3G) | ||
| FD&C RED NO. 40(WZB9127XOA) | ||
| FD&C YELLOW NO. 6(H77VEI93A8) | ||
| HYDROXYPROPYL CELLULOSE (TYPE H)(RFW2ET671P) | ||
| HYPROMELLOSES(3NXW29V3WO) | ||
| POLYETHYLENE GLYCOLS(3WJQ0SDW1A) | ||
| TALC(7SEV7J4R1U) | ||
| TITANIUM DIOXIDE(15FIX9V2JP) |